304 related articles for article (PubMed ID: 28088912)
1. Melatonin as a Therapeutic Resource for Inflammatory Visual Diseases.
Aranda ML; Fleitas MFG; Dieguez H; Iaquinandi A; Sande PH; Dorfman D; Rosenstein RE
Curr Neuropharmacol; 2017; 15(7):951-962. PubMed ID: 28088912
[TBL] [Abstract][Full Text] [Related]
2. Melatonin as a therapeutic tool in ophthalmology: implications for glaucoma and uveitis.
Rosenstein RE; Pandi-Perumal SR; Srinivasan V; Spence DW; Brown GM; Cardinali DP
J Pineal Res; 2010 Aug; 49(1):1-13. PubMed ID: 20492443
[TBL] [Abstract][Full Text] [Related]
3. Optic neuritis associated with adalimumab in the treatment of uveitis.
Li SY; Birnbaum AD; Goldstein DA
Ocul Immunol Inflamm; 2010 Dec; 18(6):475-81. PubMed ID: 20809867
[TBL] [Abstract][Full Text] [Related]
4. Treatment with melatonin after onset of experimental uveitis attenuates ocular inflammation.
Sande PH; Dorfman D; Fernandez DC; Chianelli M; Domínguez Rubio AP; Franchi AM; Silberman DM; Rosenstein RE; Sáenz DA
Br J Pharmacol; 2014 Dec; 171(24):5696-707. PubMed ID: 25131343
[TBL] [Abstract][Full Text] [Related]
5. Outcomes of Repository Corticotropin Gel for Ocular Sarcoidosis.
Oh DJ; Singh A; Kanu LN; Lobo-Chan AM; MacIntosh PW; Bhat P
Ocul Immunol Inflamm; 2022 Aug; 30(6):1420-1424. PubMed ID: 33826473
[TBL] [Abstract][Full Text] [Related]
6. Clinical manifestations and treatment outcomes of syphilitic uveitis in HIV-negative patients in China: A retrospective case study.
Zhu J; Jiang Y; Shi Y; Zheng B; Xu Z; Jia W
Medicine (Baltimore); 2017 Oct; 96(43):e8376. PubMed ID: 29069031
[TBL] [Abstract][Full Text] [Related]
7. Melatonin, an endogenous hormone, modulates Th17 cells via the reactive-oxygen species/TXNIP/HIF-1α axis to alleviate autoimmune uveitis.
Huang J; Li Z; Hu Y; Li Z; Xie Y; Huang H; Chen Q; Chen G; Zhu W; Chen Y; Su W; Chen X; Liang D
J Neuroinflammation; 2022 May; 19(1):124. PubMed ID: 35624485
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic effect of melatonin in experimental uveitis.
Sande PH; Fernandez DC; Aldana Marcos HJ; Chianelli MS; Aisemberg J; Silberman DM; Sáenz DA; Rosenstein RE
Am J Pathol; 2008 Dec; 173(6):1702-13. PubMed ID: 19008374
[TBL] [Abstract][Full Text] [Related]
9. [Use of a new anti-inflammatory agent, metiazinic acid, in ophthalmology].
Thomas C; Mignot R; Galoisy C
Bull Soc Ophtalmol Fr; 1970; 70(9):921-4. PubMed ID: 5526291
[No Abstract] [Full Text] [Related]
10. [Anterior optic neuritis do to ulcerative colitis].
Romero Aroca P; Salvat Serra M; Perena Soriano F; Martínez Salcedo I
Arch Soc Esp Oftalmol; 2001 Mar; 76(3):189-91. PubMed ID: 11283786
[TBL] [Abstract][Full Text] [Related]
11. [Intravenous corticosteroid therapy in optical nerve neuritis and uveitis].
Draeger J; Andresen P; Tamm J
Ophthalmologica; 1967; 153(1):15-28. PubMed ID: 6049141
[No Abstract] [Full Text] [Related]
12. Protective effects of intraperitoneal vitamin C, aprotinin and melatonin administration on retinal edema during experimental uveitis in the guinea pig.
Kükner AS; Kükner A; Naziroğlu M; Colakoğlu N; Celebi S; Yilmaz T; Aydemir O
Cell Biochem Funct; 2004; 22(5):299-305. PubMed ID: 15338469
[TBL] [Abstract][Full Text] [Related]
13. Neuroprotective effect of melatonin in experimental optic neuritis in rats.
Aranda ML; González Fleitas MF; De Laurentiis A; Keller Sarmiento MI; Chianelli M; Sande PH; Dorfman D; Rosenstein RE
J Pineal Res; 2016 Apr; 60(3):360-72. PubMed ID: 26882296
[TBL] [Abstract][Full Text] [Related]
14. Further Evidence on Efficacy of Diet Supplementation with Fatty Acids in Ocular Pathologies: Insights from the EAE Model of Optic Neuritis.
Locri F; Cammalleri M; Pini A; Dal Monte M; Rusciano D; Bagnoli P
Nutrients; 2018 Oct; 10(10):. PubMed ID: 30301197
[TBL] [Abstract][Full Text] [Related]
15. Chronobiotic effect of melatonin in experimental optic neuritis.
Aranda ML; Narvaez O; Altschuler F; Calanni JS; González Fleitas MF; Sande PH; Dorfman D; Concha L; Rosenstein RE
Neuropharmacology; 2021 Jan; 182():108401. PubMed ID: 33197466
[TBL] [Abstract][Full Text] [Related]
16. Improvement of uveitis and optic nerve disease by cyclosporine in a patient with multiple sclerosis.
Nussenblatt RB; Palestine AG; Chan CC; Breen L; Caruso R
Am J Ophthalmol; 1984 Jun; 97(6):790-1. PubMed ID: 6731549
[No Abstract] [Full Text] [Related]
17. TNF inhibition for ophthalmic indications: current status and outlook.
Rifkin LM; Birnbaum AD; Goldstein DA
BioDrugs; 2013 Aug; 27(4):347-57. PubMed ID: 23568177
[TBL] [Abstract][Full Text] [Related]
18. Optic neuritis with visual field defect--possible Ibuprofen-related toxicity.
Gamulescu MA; Schalke B; Schuierer G; Gabel VP
Ann Pharmacother; 2006 Mar; 40(3):571-3. PubMed ID: 16507621
[TBL] [Abstract][Full Text] [Related]
19. [Corticosteroids in ophthalmology].
Trzcińska-Dabrowska Z
Pol Tyg Lek; 1972 Jun; 27(26):1008-10. PubMed ID: 4560602
[No Abstract] [Full Text] [Related]
20. CRYOPYRIN-ASSOCIATED PERIODIC SYNDROME-ASSOCIATED UVEITIS AND PAPILLITIS.
Ma L; Lee S; Montieth A; Stephenson A; Foster CS; Anesi SD
Retin Cases Brief Rep; 2021 Mar; 15(2):149-154. PubMed ID: 30134363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
